A Prospective Study to Evaluate the ConforMIS iTotal® (PS) Knee Replacement System



Status:Recruiting
Conditions:Arthritis, Osteoarthritis (OA)
Therapuetic Areas:Rheumatology
Healthy:No
Age Range:18 - Any
Updated:11/4/2018
Start Date:May 1, 2017
End Date:May 2028
Contact:Marc Quartulli
Email:Marc.Quartulli@conformis.com
Phone:781-345-9191

Use our guide to learn which trials are right for you!

This is a prospective clinical study designed to observe the long-term clinical outcomes of
total knee arthroplasty using a patient-specific, posterior stabilized implant in patients
with osteoarthritis.

The study is prospective. Subjects will be implanted with an iTotal® PS Knee Replacement
System. The study will include a minimum of 100 subjects across up to 10 sites. The patients
enrolled in this study may represent the first cases of the iTotal PS KRS implanted at a
particular site; data collected for the first 15 patients at each site will be analyzed
separately from the rest of the enrolled population. This will provide visibility towards
determining if there exists a learning curve in the implantation process of the iTotal PS
KRS. The study sites will be located in the United States.

Inclusion Criteria:

- Clinical condition included in the approved Indications For Use for the iTotal® PS

- Osteoarthritis, as confirmed by the investigator's assessment of disease status at
screening visit that warrants a TKR procedure. Disease status is assessed by Clinical
and Radiographic assessment.

- Willingness to participate in the clinical study, to give informed consent, and to
attend all follow-up visits

- > 18 years of age

Exclusion Criteria:

- Simultaneous bilateral procedure required

- BMI > 40

- Active malignancy (defined as a history of any invasive malignancy - except non-
melanoma skin cancer), unless patient has been treated with curative intent and there
have been no clinical signs or symptoms of the malignancy for at least 5 years

- Poorly controlled diabetes

- Neuromuscular conditions which prevent patient from participating in study activities

- Active local or systemic infection

- Immunocompromised

- Fibromyalgia or other general body pain related condition

- Rheumatoid arthritis or other forms of inflammatory joint disease

- Loss of bone or musculature, osteonecrosis, neuromuscular or vascular compromise in
the area of the joint to be operated on, to an extent that the procedure is
unjustified

- Diagnosed with or receiving treatment for Osteoporosis

- Other physical disability affecting the hips, spine, or contralateral knee

- Severe instability due to advanced loss of osteochondral structure

- Prior arthroplasty of the affected knee, including High Tibial Osteotomy (HTO)

- Unwilling or unable to comply with study requirements

- Participation in another clinical study which would confound results

- Allergy to any of the implant materials
We found this trial at
4
sites
Morrisville, Vermont 05661
Principal Investigator: Bryan Huber, MD
Phone: 802-888-8405
?
mi
from
Morrisville, VT
Click here to add this to my saved trials
Austin, Texas 78751
Principal Investigator: Eric M Heinrich, MD
Phone: 512-583-0217
?
mi
from
Austin, TX
Click here to add this to my saved trials
Chapel Hill, North Carolina 27599
Phone: 919-966-5495
?
mi
from
Chapel Hill, NC
Click here to add this to my saved trials
2828 1st Avenue
Huntington, West Virginia 25702
Phone: 304-525-6905
?
mi
from
Huntington, WV
Click here to add this to my saved trials